Similar articles for PMID: 27909576

Year	Number of Results
2016	12
2017	14
2018	13
2019	17
2020	15
2021	17
2022	11
2023	15
2024	3

1

Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library.

Pascoalino BS, Courtemanche G, Cordeiro MT, Gil LH, Freitas-Junior L. Pascoalino BS, et al. F1000Res. 2016 Oct 14;5:2523. doi: 10.12688/f1000research.9648.1. eCollection 2016. F1000Res. 2016. PMID: 27909576 Free PMC article.

2

Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.

Adcock RS, Chu YK, Golden JE, Chung DH. Adcock RS, et al. Antiviral Res. 2017 Feb;138:47-56. doi: 10.1016/j.antiviral.2016.11.018. Epub 2016 Dec 3. Antiviral Res. 2017. PMID: 27919709

3

Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.

Loe MWC, Lee RCH, Chu JJH. Loe MWC, et al. Antiviral Res. 2019 Dec;172:104637. doi: 10.1016/j.antiviral.2019.104637. Epub 2019 Oct 25. Antiviral Res. 2019. PMID: 31669333

4

Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.

Gharbi-Ayachi A, Santhanakrishnan S, Wong YH, Chan KWK, Tan ST, Bates RW, Vasudevan SG, El Sahili A, Lescar J. Gharbi-Ayachi A, et al. J Virol. 2020 Oct 14;94(21):e00794-20. doi: 10.1128/JVI.00794-20. Print 2020 Oct 14. J Virol. 2020. PMID: 32796069 Free PMC article.

5

Identification of Inhibitors of ZIKV Replication.

Morales Vasquez D, Park JG, Ávila-Pérez G, Nogales A, de la Torre JC, Almazan F, Martinez-Sobrido L. Morales Vasquez D, et al. Viruses. 2020 Sep 18;12(9):1041. doi: 10.3390/v12091041. Viruses. 2020. PMID: 32961956 Free PMC article.

6

The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment.

Riva L, Goellner S, Biering SB, Huang CT, Rubanov AN, Haselmann U, Warnes CM, De Jesus PD, Martin-Sancho L, Terskikh AV, Harris E, Pinkerton AB, Bartenschlager R, Chanda SK. Riva L, et al. J Virol. 2021 Oct 27;95(22):e0099621. doi: 10.1128/JVI.00996-21. Epub 2021 Sep 1. J Virol. 2021. PMID: 34468177 Free PMC article.

7

Novel Nonnucleoside Inhibitors of Zika Virus Polymerase Identified through the Screening of an Open Library of Antikinetoplastid Compounds.

Sáez-Álvarez Y, Jiménez de Oya N, Del Águila C, Saiz JC, Arias A, Agudo R, Martín-Acebes MA. Sáez-Álvarez Y, et al. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0089421. doi: 10.1128/AAC.00894-21. Epub 2021 Aug 17. Antimicrob Agents Chemother. 2021. PMID: 34152807 Free PMC article.

8

High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection.

Xu H, Cheng M, Chi X, Liu X, Zhou J, Lin T, Yang W. Xu H, et al. J Virol. 2019 Aug 28;93(18):e00758-19. doi: 10.1128/JVI.00758-19. Print 2019 Sep 15. J Virol. 2019. PMID: 31270223 Free PMC article.

9

Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors.

Zhang JW, Wang H, Liu J, Ma L, Hua RH, Bu ZG. Zhang JW, et al. Virol Sin. 2021 Jun;36(3):476-489. doi: 10.1007/s12250-020-00316-0. Epub 2020 Nov 24. Virol Sin. 2021. PMID: 33231855 Free PMC article.

10

Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice.

Li C, Zhu X, Ji X, Quanquin N, Deng YQ, Tian M, Aliyari R, Zuo X, Yuan L, Afridi SK, Li XF, Jung JU, Nielsen-Saines K, Qin FX, Qin CF, Xu Z, Cheng G. Li C, et al. EBioMedicine. 2017 Oct;24:189-194. doi: 10.1016/j.ebiom.2017.09.034. Epub 2017 Sep 28. EBioMedicine. 2017. PMID: 29033372 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year